About Us

Company Overview

Cardiol Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease.

The Company brings together a wealth of research and development experience, advanced manufacturing capabilities, and a Management team, Board of Directors, and Scientific Advisory Board comprising business and thought leaders with extensive industry experience and expertise in commercializing proprietary drugs. Learn more…

Cardiol recently received approval from the U.S. FDA for its Investigational New Drug (IND) application to commence a Phase II/III, double-blind, placebo-controlled clinical trial investigating the efficacy and safety of its lead clinical product, CardiolRx™, in hospitalized COVID-19 patients with a prior history of, or risk factors for, cardiovascular disease (CVD). Learn more…CardiolRx™ is an ultra-pure, high concentration cannabidiol oral formulation that is pharmaceutically produced, manufactured under cGMP, and THC free*. Learn more…

Cardiol is also planning a Phase II international trial of CardiolRx™ in acute myocarditis, a condition caused by inflammation in heart tissue, which remains the most common cause of sudden cardiac death in people less than 35 years of age, Learn more… and developing proprietary cannabidiol formulations for the treatment of chronic heart failure. Chronic heart failure is the leading cause of death and hospitalization in North America, with associated annual healthcare costs in the U.S. alone exceeding $30 billion. Learn more…

The Company has research collaborations focused on developing a subcutaneous cannabidiol formulation for heart failure underway at international centers of excellence, including the Houston Methodist DeBakey Heart & Vascular Center, the University of Alberta, and TecSalud del Tecnológico de Monterrey, Mexico. Learn more…

Cardiol recently launched its commercial product, CortalexTM, an extra-strength formulation (100 mg/mL concentration) of cannabidiol oil that is pharmaceutically produced to be free of THC*. Cardiol believes Cortalex™ is the purest form of cannabidiol oil available in Canada. Cortalex™ is manufactured exclusively for Cardiol by Toronto-based Dalton Pharma Services (Dalton). With over 20 years of proven experience in developing and manufacturing specialty pharmaceuticals, Dalton’s Health Canada approved, FDA registered, cGMP facility meets the highest quality standards set by the pharmaceutical industry. This quality standard ensures every bottle of Cortalex™ has a consistent composition and is THC free*. Learn more…

*<10 ppm